SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-20-126370
Filing Date
2020-04-29
Accepted
2020-04-29 16:47:05
Documents
7
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d923212d10ka.htm 10-K/A 529392
2 EX-31.3 d923212dex313.htm EX-31.3 3187
3 EX-31.4 d923212dex314.htm EX-31.4 3109
4 GRAPHIC g923212g0428110531986.jpg GRAPHIC 675
5 GRAPHIC g923212g0428110532890.jpg GRAPHIC 683
6 GRAPHIC g923212g0428110534139.jpg GRAPHIC 11574
7 GRAPHIC g923212g0428110534357.jpg GRAPHIC 10810
  Complete submission text file 0001193125-20-126370.txt   570181
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33038 | Film No.: 20831100
SIC: 2834 Pharmaceutical Preparations